You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NPR reports that the first person in the US to undergo a CRISPR-based treatment for sickle-cell disease continues to do well nearly a year after treatment.
Researchers are wondering how the COVID-19 pandemic may affect results from clinical trials that continued and how to account for that influence, ScienceInsider reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
The cloud-based personalized medicine software company will stay in Cambridge, Massachusetts and will become a wholly-owned subsidiary of the institute.
Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies.
Researchers presented data suggesting that pharma companies are using basket studies to identify molecularly defined patient subsets who might benefit from their drugs.
The partners will explore the use of Biocept's liquid biopsy technology to identify and detect biomarkers in ER-positive breast cancer patients.
CHICAGO (GenomeWeb) – Research presented at the annual meeting of the American Society of Clinical Oncology this week included a wealth of data from programs using next-generation sequencing to guide treatment for cancer patients.
This article has been updated with additional information from Sarah Cannon Research Institute.Originally published July 2.
NEW YORK (GenomeWeb News) – Sarah Cannon Research Institute and AstraZeneca said today that they will work together to advance drugs in AstraZeneca's pipeline with a personalized medicine strategy.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.